These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35946051)

  • 1. Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.
    Tazinkeng NN; Teuwafeu DG; Asombang AW; Agbor VN; Bloom SM; Nkhoma AN; Mohareb AM; Luma HN
    Liver Int; 2022 Nov; 42(11):2396-2402. PubMed ID: 35946051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-epidemiology of human immunodeficiency virus, hepatitis B virus and hepatitis C virus: a cross-sectional survey in a rural setting of the West region of Cameroon.
    Nansseu JR; Mbogning DM; Monamele GC; Tamoh SF; Gonsu HK; Kouanfack C; Yanwou YN; Sando Z
    Pan Afr Med J; 2017; 28():201. PubMed ID: 29610639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
    Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
    PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study.
    Frambo AA; Atashili J; Fon PN; Ndumbe PM
    BMC Res Notes; 2014 Jun; 7():394. PubMed ID: 24965844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
    Kamga Wouambo R; Panka Tchinda G; Kagoue Simeni LA; Djouela Djoulako PD; Yateu Wouambo CI; Tamko Mella GF; Tchoumi Leuwat EP; Bello D; Fokam J
    BMC Infect Dis; 2023 Dec; 23(1):875. PubMed ID: 38093205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    Evans H; Balasegaram S; Douthwaite S; Hunter L; Kulasegaram R; Wong T; Querol-Rubiera A; Nebbia G
    PLoS One; 2018; 13(7):e0198520. PubMed ID: 30044779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses among haemodialysis patients in two newly opened centres in Cameroon.
    Luma HN; Halle MP; Eloumou SAFB; Azingala F; Kamdem F; Donfack-Sontsa O; Ashuntantang G
    Pan Afr Med J; 2017; 27():235. PubMed ID: 28979637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HBV and HCV Among Diabetes Mellitus Patients Attending University of Gondar Hospital, Northwest Ethiopia.
    Fasil A; Geremew D; Bewket G; Kiflie A; Abebe M; Biadgo B
    Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Risk Factors of HBV and HCV Co-Infection Among People Living with HIV in an Egyptian Setting.
    El-Ghitany EM; Farghaly AG; Alkassabany YM
    Curr HIV Res; 2021; 19(6):514-524. PubMed ID: 34353267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study.
    Seyoum E; Demissie M; Worku A; Mulu A; Abdissa A; Berhane Y
    PLoS One; 2022; 17(4):e0267230. PubMed ID: 35452472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C: neglected diseases among health care workers in Cameroon.
    Fritzsche C; Becker F; Hemmer CJ; Riebold D; Klammt S; Hufert F; Akam W; Kinge TN; Reisinger EC
    Trans R Soc Trop Med Hyg; 2013 Mar; 107(3):158-64. PubMed ID: 23303802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study.
    Makuza JD; Nisingizwe MP; Rwema JOT; Dushimiyimana D; Habimana DS; Umuraza S; Serumondo J; Ngwije A; Semakula M; Gupta N; Nsanzimana S; Janjua NZ
    BMJ Open; 2020 Jul; 10(7):e036711. PubMed ID: 32660951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.